focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Estimated NAV at 30 April 2015

29 May 2015 07:05

RNS Number : 5721O
Standard Life Euro Pri Eqty Tst PLC
29 May 2015
 

29 May 2015

STANDARD LIFE EUROPEAN PRIVATE EQUITY TRUST PLC ("SLEPET" OR "THE COMPANY") ANNOUNCES ITS ESTIMATED NET ASSET VALUE ("NAV") AT 30 APRIL 2015

· ESTIMATED NAV AT 30 APRIL 2015 WAS 269.9 PENCE PER SHARE (NAV AT 31 MARCH 2015 WAS 268.6 PENCE PER SHARE)

· SLEPET RECEIVED £12.3 MILLION OF DISTRIBUTIONS AND PAID £1.0 MILLION OF DRAW DOWNS DURING THE MONTH OF APRIL

· SLEPET HAD £270.1 MILLION OF OUTSTANDING COMMITMENTS AT 30 APRIL 2015

SLEPET's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which SLEPET has holdings. In the case of SLEPET's valuation at 30 April 2015, 100% of the reported portfolio valuations were dated 31 March 2015.

 

Estimated NAV

At 30 April 2015, SLEPET's estimated NAV was 269.9 pence per share (estimated net assets £424.6 million), representing a 0.5% per share increase from the NAV at 31 March 2015 of 268.6 pence per share (net assets £422.5 million).

 

Draw downs and distributions

SLEPET paid £1.0 million of draw downs and received £12.3 million of distributions during the month. The distributions received generated net realised gains and income of £6.9 million.

 

Commitments

A new commitment of €30.0 million was made to Equistone Partners Europe Fund V in April. The Company had £270.1 million of outstanding commitments at 30 April 2015. After undertaking a detailed review, the Manager continues to believe that up to £50 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

Balance sheet and credit facility

The Company had liquid resources of £58.4 million at 30 April 2015, comprising a cash balance of £26.7 million and £31.7 million invested at value (£29.5 million at cost) in UK and European equity index tracker funds. The Company has an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

Future announcements

The Company is expecting to announce its estimated NAV at 31 May 2015 on or around 12 June 2015.

 

 

 

 

Additional detail about SLEPET's NAV and investment diversification can be found on SLEPET's website. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

For further information please contact Peter McKellar or Roger Pim at SL Capital Partners LLP (0131 245 0055)

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

Valuation Methodology

Unquoted investments are stated at the directors' estimate of fair value and follow the recommendations of EVCA and BVCA. The estimate of fair value is normally the latest valuation placed on a fund by its manager at the balance sheet date. The valuation policies used by the manager in undertaking that valuation will generally be in line with the joint publication from EVCA and BVCA, 'International Private Equity and Venture Capital Valuation guidelines'. Where formal valuations are not completed at the balance sheet date the last available valuation from the fund manager is adjusted for any subsequent cashflows occurring between the valuation date and the balance sheet date. The Company's Manager may further adjust such valuations to reflect any changes in circumstances from the last manager's formal valuation date to arrive at the estimate of fair value. Quoted investments are valued based on quoted prices as of the last day of the relevant period.

The Company intends to release regular estimated NAV updates around ten business days after each month end, while continuing to issue quarterly trading statements. A breakdown of SLEPET's portfolio can be obtained in the latest monthly factsheet, which is published on the Manager's website at www.slcapital.com/IT_European_Private_Equity/getLatest.pdf

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVPGUPGAUPAGMR
Date   Source Headline
4th Dec 20177:00 amRNSAnnual Financial Report
30th Nov 20174:49 pmRNSDirectorate Change
14th Nov 20177:00 amRNSEstimated Net Asset Value at 31 October 2017
9th Nov 20174:50 pmRNSHolding(s) in Company
16th Oct 20174:14 pmRNSHolding(s) in Company
13th Oct 20177:00 amRNSEstimated Net Asset Value at 30 September 2017
3rd Oct 201712:37 pmRNSQuarterly Disclosure
20th Sep 20177:00 amRNSEstimated Net Asset Value at 31 August 2017
20th Sep 20177:00 amRNSQuarterly Trading Statement
13th Sep 20175:05 pmRNSDirector Declaration
25th Aug 20174:38 pmRNSDirector/PDMR Shareholding
17th Aug 20174:08 pmRNSHolding(s) in Company
14th Aug 20177:00 amRNSEstimated Net Asset Value at 31 July 2017
10th Aug 20174:08 pmRNSDirector/PDMR Shareholding
4th Aug 20171:54 pmRNSDirector/PDMR Shareholding
4th Aug 20171:53 pmRNSDirector/PDMR Shareholding
14th Jul 20177:00 amRNSEstimated Net Asset Value at 30 June 2017
4th Jul 201712:59 pmRNSQuarterly Disclosure
3rd Jul 20172:46 pmRNSUpdate research from QuotedData
14th Jun 20177:00 amRNSEstimated Net Asset Value at 31 May 2017
7th Jun 20171:48 pmRNSDirector/PDMR Shareholding
7th Jun 20177:00 amRNSHalf-year Report
15th May 20177:00 amRNSEstimated Net Asset Value at 30 April 2017
8th May 20174:48 pmRNSHolding(s) in Company
2nd May 20171:09 pmRNSEdison update on Standard Life Private Eqty Trst
18th Apr 20177:00 amRNSEstimated Net Asset Value at 31 March 2017
4th Apr 201712:34 pmRNSQuarterly Disclosure
24th Mar 20177:00 amRNSEstimated Net Asset Value at 28 February 2017
24th Mar 20177:00 amRNSQuarterly Trading Statement
22nd Feb 201710:22 amRNSUpdate research from QuotedData
14th Feb 20177:00 amRNSEstimated Net Asset Value at 31 January 2017
7th Feb 20179:38 amRNSDirector/PDMR Shareholding
7th Feb 20179:37 amRNSDirector/PDMR Shareholding
31st Jan 20173:09 pmRNSChange of Name
24th Jan 20172:18 pmRNSResult of AGM
16th Jan 20177:00 amRNSEstimated Net Asset Value at 31 December 2016
4th Jan 20172:24 pmRNSQuarterly Disclosure
21st Dec 201612:33 pmRNSHolding(s) in Company
21st Dec 20167:00 amRNSChange of Broker
14th Dec 20167:00 amRNSEstimated Net Asset Value at 30 November 2016
5th Dec 201611:21 amRNSAnnual Report and Notice of Annual General Meeting
5th Dec 20167:00 amRNSChange of Advisors
5th Dec 20167:00 amRNSEstimated Net Asset Value at 31 October 2016
5th Dec 20167:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Dec 20167:00 amRNSAnnual Financial Report
14th Nov 20167:00 amRNSEstimated Net Asset Values as at 31 October 2016
7th Nov 201611:04 amRNSEdison review: Standard Life Euro Priv Eqty Trst
14th Oct 20167:00 amRNSEstimated Net Asset Value as at 30 September 2016
10th Oct 20163:53 pmRNSDirector Declaration
6th Oct 201611:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.